These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20727962)

  • 21. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.
    Grace AA; Gomes FV
    Schizophr Bull; 2019 Jan; 45(1):148-157. PubMed ID: 29385549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia.
    Walker E; Mittal V; Tessner K
    Annu Rev Clin Psychol; 2008; 4():189-216. PubMed ID: 18370616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral and neurochemical repercussions of hippocampal network activity blockade during the neonatal period.
    Ponten H; Sönniksen K; Abrahamsson T; Waters N; Gustafsson B; Hanse E; Groc L
    Brain Res Dev Brain Res; 2005 Mar; 155(1):81-6. PubMed ID: 15763278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optogenetic induction of the schizophrenia-related endophenotype of ventral hippocampal hyperactivity causes rodent correlates of positive and cognitive symptoms.
    Wolff AR; Bygrave AM; Sanderson DJ; Boyden ES; Bannerman DM; Kullmann DM; Kätzel D
    Sci Rep; 2018 Aug; 8(1):12871. PubMed ID: 30150758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia.
    Bitanihirwe BK; Peleg-Raibstein D; Mouttet F; Feldon J; Meyer U
    Neuropsychopharmacology; 2010 Nov; 35(12):2462-78. PubMed ID: 20736993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Development of Parvalbumin-, Somatostatin-, and Cholecystokinin-Expressing Neurons in Rat Brain following Prenatal Immune Activation and Maternal Iron Deficiency.
    Boksa P; Zhang Y; Nouel D; Wong A; Wong TP
    Dev Neurosci; 2016; 38(5):342-353. PubMed ID: 28214898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivity.
    Grimm CM; Aksamaz S; Schulz S; Teutsch J; Sicinski P; Liss B; Kätzel D
    Transl Psychiatry; 2018 Oct; 8(1):212. PubMed ID: 30301879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phencyclidine administration during neurodevelopment alters network activity in prefrontal cortex and hippocampus in adult rats.
    Kjaerby C; Hovelsø N; Dalby NO; Sotty F
    J Neurophysiol; 2017 Aug; 118(2):1002-1011. PubMed ID: 28539393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Laboratory Studies on Cannabinoids and Psychosis.
    Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
    Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
    Jodo E
    J Physiol Paris; 2013 Dec; 107(6):434-40. PubMed ID: 23792022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.
    Lipska BK; Jaskiw GE; Weinberger DR
    Neuropsychopharmacology; 1993 Aug; 9(1):67-75. PubMed ID: 8397725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less.
    Swerdlow NR; Halim N; Hanlon FM; Platten A; Auerbach PP
    Brain Res Bull; 2001 May; 55(1):71-7. PubMed ID: 11427340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benzodiazepines and schizophrenia, a review of the literature].
    Gaillard R; Ouanas A; Spadone C; Llorca PM; Lôo H; Baylé FJ
    Encephale; 2006; 32(6 Pt 1):1003-10. PubMed ID: 17372546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation.
    Lodge DJ; Grace AA
    Neuropsychopharmacology; 2006 Jul; 31(7):1356-61. PubMed ID: 16319915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia.
    Lisman JE; Pi HJ; Zhang Y; Otmakhova NA
    Biol Psychiatry; 2010 Jul; 68(1):17-24. PubMed ID: 20553749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia.
    Gray JA; Joseph MH; Hemsley DR; Young AM; Warburton EC; Boulenguez P; Grigoryan GA; Peters SL; Rawlins JN; Taib CT
    Behav Brain Res; 1995 Nov; 71(1-2):19-31. PubMed ID: 8747172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stress and psychotic transition: A literature review].
    Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
    Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social vs. environmental stress models of depression from a behavioural and neurochemical approach.
    Venzala E; García-García AL; Elizalde N; Tordera RM
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):697-708. PubMed ID: 22743048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms.
    Thompson JL; Pogue-Geile MF; Grace AA
    Schizophr Bull; 2004; 30(4):875-900. PubMed ID: 15954196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.